Medigene AG (MDG1)の価格はいくらですか

Medigene AG (MDG1)の価格は$0.14942078です

Medigene AG (MDG1)の時価総額は何ですか

Medigene AG (MDG1)の時価総額は$3.86Mです

Medigene AG（MDG1）PBR（株価純資産倍率）

Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Université de Montréal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.

年	P/B比率	変化
2026 (TTM)	0.08	-95.37%
2023	1.68	25.83%
2022	1.33	-14.69%
2021	1.56	-3.33%
2020	1.62	35.42%
2019	1.19	-67.18%
2018	3.64	-42.42%
2017	6.32	5.15%
2016	6.01	95.80%
2015	3.07	75.28%
2014	1.75	-0.10%
2013	1.75	9.93%
2012	1.60	112.55%
2011	0.75	-57.92%
2010	1.78	-24.51%
2009	2.36	4.86%
2008	2.25	35.63%
2007	1.66	15.41%
2006	1.44	-51.96%
2005	3.00	55.45%
2004	1.93	0.00%

年

P/B比率

変化

2026 (TTM)

0.08

-95.37%

2023

1.68

25.83%

2022

1.33

-14.69%

2021

1.56

-3.33%

2020

1.62

35.42%

2019

1.19

-67.18%

2018

3.64

-42.42%

2017

6.32

5.15%

2016

6.01

95.80%

2015

3.07

75.28%

2014

1.75

-0.10%

2013

1.75

9.93%

2012

1.60

112.55%

2011

0.75

-57.92%

2010

1.78

-24.51%

2009

2.36

4.86%

2008

2.25

35.63%

2007

1.66

15.41%

2006

1.44

-51.96%

2005

3.00

55.45%

2004

1.93

0.00%

企業	P/B比率	P/B比率の差	国
Vertex Pharmaceuticals Incorporated VRTX.US	6.3419	8,051.54%	US
Argenx SE ARGX.US	6.2413	7,922.24%	NL
Lonza Group AG LONN.SW	-	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR
UCB S.A. UCB.BR	3.4612	4,348.84%	BE

企業

P/B比率

P/B比率の差

国